Zavzpret (Zavegepant hydrochloride)

If you are considering the import of Zavegepant to India, please be aware that Zavegepant hydrochloride can be imported by patients or government hospitals solely in the name of the patients. The following documentation is essential for the successful import of this medication:

Required Documentation for Import:

• A valid prescription from a qualified medical practitioner.
  
• Diagnostic reports of the patient.
  
• Government-issued identification proof for the patient, as recognized by the Government of India.

• The order for Zavegepant will be confirmed upon the receipt of the following documents:
  
• A valid prescription from a qualified doctor.
  
• An import permit, if applicable.
  

Availability of Zavegepant in India: 

Zavegepant is classified as a prescription pharmaceutical drug. Consequently, it legally requires a medical prescription to be dispensed. Indian Pharma Network (IPN) specializes in facilitating the import of cancer medicines through named patient supply (NPS), ensuring transparency and authenticity by sourcing from reputable suppliers in the USA, Canada, Europe, and Australia.

Zavegepant can be made accessible to patients, doctors, and hospitals in various cities across India, including but not limited to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune. To confirm an order, a valid prescription from a doctor and an import permit will be required.

IPN (Indian Pharma Network) is dedicated to facilitating the supply of Zavegepant (prescription medicines) to locations both within India and worldwide, while adhering to relevant legal requirements.

For inquiries regarding the price of Zavegepant in India and to initiate the ordering process, please reach out to us through the following contact details:

Our commitment lies in assuring quality and timely delivery to meet the healthcare needs of patients and medical professionals across the globe.

Is Zavegepant fda-approved?

The U.S. Food and Drug Administration (FDA) has approved Zavegepant, the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray for the acute treatment of migraine with or without aura in adults.

What are the common side effects of Zavegepant?

The most common adverse reactions observed in patients using ZAVZPRET, with an incidence of at least 2% and greater than placebo, include taste disorders, nausea, nasal discomfort, and vomiting. If you experience any adverse reactions, consult your healthcare provider.

When was Zavegepant FDA-approved?

The Zavegepant was approved by Mar 10, 2023.

Is Zavzpret available yet?

Zavegepant nasal spray is now available for the acute treatment of migraine with or without aura in adults. Zavzpret is a calcitonin gene-related peptide (CGRP) receptor antagonist. You can refer Indian Pharma Networks for more information.

Do I need a prescription for Zavegepant?

Zavegepant is a prescription medicine used in adults for the acute treatment of migraine attacks with or without aura. Zavegepant is not used to prevent migraine attacks.